Literature DB >> 26672845

Co-Incidence or Co-Existence? Acute Lymphoblastic Leukaemia in HbE-alpha Thalassaemia: A Case Report with Review of Literature.

Rithika Rajendran1, Febe Renjitha Suman2, Aruna Rajendran3, Julius Xavier Scott4.   

Abstract

Haemoglobin E (HbE) is a Haemoglobin variant that commonly occurs in many places in Asia. As β thalassaemia and α thalassaemia also occur in the same regions, the co-inheritance of these conditions leads to various phenotypic forms. HbE α thalassaemia is less common and of a milder phenotype than HbE β thalassaemia. Though malignancies are one of the complications in thalassaemia, occurrence of leukaemia is a rare event. Here we present a case of a two-year-old male child co-presenting with pre B acute lymphoblastic leukaemia (ALL) with MLL rearrangement and HbE alpha thalassaemia. The child is on remission 12 months post-therapy with standard ALL high risk protocol with no minimal residual disease (MRD). Haematological and oncological conditions coexisting at presentation is a challenge to therapy. This case is described for its rarity. Informed consent has been obtained from the parents.

Entities:  

Keywords:  Haemoglobin variants; Paediatric leukaemia; Thalassaemic syndrome

Year:  2015        PMID: 26672845      PMCID: PMC4668511          DOI: 10.7860/JCDR/2015/14711.6796

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

Review 1.  Pathogenetic aspects of immune deficiency associated with beta-thalassemia.

Authors:  Dimitrios Farmakis; Anastasios Giakoumis; Evaggelos Polymeropoulos; Athanasios Aessopos
Journal:  Med Sci Monit       Date:  2003-01

2.  Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.

Authors:  Ersi Voskaridou; Evangelos Terpos; Veroniki Komninaka; Eftyhios Eftyhiadis; Marina Mantzourani; Dimitris Loukopoulos
Journal:  Br J Haematol       Date:  2002-01       Impact factor: 6.998

3.  Thalassemia major and malignancies.

Authors:  A Russo; G Schilirò
Journal:  Am J Hematol       Date:  1987-01       Impact factor: 10.047

4.  Survival and causes of death in thalassaemia major.

Authors:  M G Zurlo; P De Stefano; C Borgna-Pignatti; A Di Palma; A Piga; C Melevendi; F Di Gregorio; M G Burattini; S Terzoli
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age.

Authors:  F G Behm; S C Raimondi; J L Frestedt; Q Liu; W M Crist; J R Downing; G K Rivera; J H Kersey; C H Pui
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

6.  [Acute lymphoblastic leukemia after tuberculosis in a 8-year old greek boy with homozygous beta-thalassemia (author's transl)].

Authors:  B Lau; R Eife; F Lampert
Journal:  Klin Padiatr       Date:  1975-07       Impact factor: 1.349

7.  Hematological malignancies complicating β-thalassemia syndromes: a single center experience.

Authors:  Samin Alavi; Alieh Safari; Elham Sadeghi; Somayeh Amiri
Journal:  Blood Res       Date:  2013-06-25

8.  Thalassemia Intermedia and Acute Lymphoblastic Leukemia: Is it a Coincidental Double Diagnosis?

Authors:  Deniz Tuğcu; Zeynep Karakaş; Müge Gökçe; Leyla Ağaoğlu; Ayşegül Unüvar; Ebru Sarıbeyoğlu; Arzu Akçay; Omer Devecioğlu
Journal:  Turk J Haematol       Date:  2014-09-05       Impact factor: 1.831

  8 in total
  1 in total

1.  Correspondence: Acute Lymphoblastic Leukaemia and HbE-alpha Thalassaemia.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  J Clin Diagn Res       Date:  2016-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.